In addition, a significant correlation was found between MAL2 expression and the smoking status (p = 0.0192) and pathologic stage (p = 0.0104) of the bladder cancer patients in cohort 2 and between MAL2 expression and FTO expression (Table 5). This evidence concerns the gene MAL2 and urinary bladder carcinoma.